BioCentury | Aug 7, 2015
Financial News

Antiva raises $16M in series B

...Wende Hutton and Sofinnova's David Kabakoff will join Antiva's board. Antiva was formerly known as Hera Therapeutics Inc. BC...
BioCentury | Sep 22, 2014
Clinical News

Hera Therapeutics preclinical data

...were presented at the International Papillomavirus Conference in Seattle. HTI-1968 is a topical direct-acting antiviral. Hera Therapeutics Inc....
Items per page:
1 - 2 of 2
BioCentury | Aug 7, 2015
Financial News

Antiva raises $16M in series B

...Wende Hutton and Sofinnova's David Kabakoff will join Antiva's board. Antiva was formerly known as Hera Therapeutics Inc. BC...
BioCentury | Sep 22, 2014
Clinical News

Hera Therapeutics preclinical data

...were presented at the International Papillomavirus Conference in Seattle. HTI-1968 is a topical direct-acting antiviral. Hera Therapeutics Inc....
Items per page:
1 - 2 of 2